A Study to Evaluate the Effect of a Single Oral Dose of ZX-7101A on the QTc Interval in Healthy Subjects

NCT05955027 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human

Interventions

DRUG: ZX-7101A
DRUG: Placebo

Sponsor

Nanjing Zenshine Pharmaceuticals